abs310.txt	background		persons	living	with	hiv	(plwh)	have	an	elevated	risk	for	certaintypes	of	cancer		with	modern	antiretroviral	therapy		plwh	are	aging	and	cancerrates	are	changing	objective		to	project	cancer	incidence	rates	and	burden	(number	of	new	cancerdiagnoses)	among	adult	plwh	in	the	united	states	through	2030	design		descriptive	setting		hiv/aids	cancer	match	study	to	project	cancer	rates	and	hiv	optimizationand	prevention	economics	model	to	project	hiv	prevalence	participants		hiv-infected	adults	measurements		projected	cancer	rates	and	burden	among	hiv-infected	adults	in	theunited	states	by	age	during	2006	to	2030	for	aids-defining	cancer	(adc)-that	is	kaposi	sarcoma		non-hodgkin	lymphoma		and	cervical	cancer-and	certain	types	ofnon-aids-defining	cancer	(nadc)		all	other	cancer	types	were	combined	results		the	proportion	of	adult	plwh	in	the	united	states	aged	65	years	or	olderis	projected	to	increase	from	8	5%	in	2010	to	21	4%	in	2030		age-specific	ratesare	projected	to	decrease	through	2030	across	age	groups	for	kaposi	sarcoma	non-hodgkin	lymphoma		cervical	cancer		lung	cancer		hodgkin	lymphoma		and	othercancer	types	combined		and	among	those	aged	65	years	or	older	for	colon	cancer	prostate	cancer	rates	are	projected	to	increase		the	estimated	total	cancerburden	in	plwh	will	decrease	from	8150	cases	in	2010	(2730	of	adc	and	5420	ofnadc)	to	6690	cases	in	2030	(720	of	adc	and	5980	of	nadc)		in	2030		prostatecancer	(n	=	1590)	and	lung	cancer	(n	=	1030)	are	projected	to	be	the	most	commoncancer	types	limitation		projections	assume	that	current	trends	in	cancer	incidence	rates		hivtransmission		and	survival	will	continue	conclusion		the	cancer	burden	among	plwh	is	projected	to	shift		with	prostate	andlung	cancer	expected	to	emerge	as	the	most	common	types	by	2030		cancer	willremain	an	important	comorbid	condition		and	expanded	access	to	hiv	therapies	andcancer	prevention		screening		and	treatment	is	needed	primary	funding	source		national	cancer	institute	
